Inspiratory Muscle Training in American Football Players
NCT ID: NCT07246655
Last Updated: 2026-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2025-11-20
2026-01-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Functional Respiratory Muscle Training on Respiratory Function and Physical Performance
NCT06494930
Arterial Stiffness Intercostal Muscle Oxygenation and Aerobic-Anaerobic Capacity in Elite American Football Players
NCT07319962
Inspiratory and Expiratory Muscle Training in Adolescent Volleyball Players
NCT06759779
Percussive Therapy in U19 Males: Flexibility, Balance, Jump
NCT07152275
Effects of Inspiratory Muscle Training Combined With Circadian Rhythm-based Running Programs in Children Male Football Players
NCT07170891
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All athletes in both groups will continue their regular team-based strength and conditioning routines throughout the 8-week study period. Participants in the IMT Group will additionally perform a high-intensity inspiratory muscle training protocol three times per week, with training loads set at approximately 80% of each athlete's measured maximal inspiratory pressure (MIP). Training intensity will be reassessed bi-weekly and adjusted according to updated MIP values to ensure that the prescribed load is maintained throughout the intervention. The Control Group will not receive inspiratory muscle training and will perform only their routine training program.
All athletes will be evaluated at baseline and at the end of the 8-week intervention. Outcome measures will include respiratory muscle strength (MIP/MEP), dynamic and static balance performance, core muscle endurance (McGill core endurance tests), and sport-specific performance parameters relevant to American football. Assessments will be carried out by the same researcher to minimize inter-rater variability, and all training sessions will be supervised to ensure protocol adherence.
Data will be collected and recorded systematically at both time points, and all procedures will follow established ATS/ERS guidelines for respiratory muscle testing and standard sports science assessment protocols.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-Intensity Inspiratory Muscle Training Group
Inspiratory muscle training Team strength and conditioning training
High-Intensity Inspiratory Muscle Training
Participants in the IMT Group will perform an 8-week high-intensity inspiratory muscle training protocol in addition to their routine team-based strength and conditioning program. Training loads will be individualized based on each athlete's maximal inspiratory pressure (MIP) and set at approximately 80% of MIP. Loads will be reassessed every two weeks, and the resistance will be adjusted to maintain the prescribed intensity.
Control Group
Team strength and conditioning training
Control Group
Participants in the Control Group will continue their standard team-based strength, conditioning, and field training sessions throughout the 8-week study period. They will not receive inspiratory muscle training or any additional respiratory intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High-Intensity Inspiratory Muscle Training
Participants in the IMT Group will perform an 8-week high-intensity inspiratory muscle training protocol in addition to their routine team-based strength and conditioning program. Training loads will be individualized based on each athlete's maximal inspiratory pressure (MIP) and set at approximately 80% of MIP. Loads will be reassessed every two weeks, and the resistance will be adjusted to maintain the prescribed intensity.
Control Group
Participants in the Control Group will continue their standard team-based strength, conditioning, and field training sessions throughout the 8-week study period. They will not receive inspiratory muscle training or any additional respiratory intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 18 to 35 years
* Actively participating in team-based training at the time of study enrollment
* Minimum 1 year of organized American football training experience
* Able to perform high-intensity inspiratory muscle training (IMT)
* No history of acute respiratory infection in the past 4 weeks
* Voluntary agreement to participate and ability to provide informed consent
Exclusion Criteria
* History of major cardiovascular, neurological, or musculoskeletal disorders affecting performance
* Current rib, spine, abdominal, or core muscle injury
* Diagnosed pulmonary hypertension or unstable cardiac conditions
* Recent surgery (within the past 3 months)
* Inability to correctly perform inspiratory muscle training (IMT) device technique
* Participation in another interventional study within the last 30 days
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Namik Kemal University
OTHER
Yeditepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elif Develi, PhD.
Role: PRINCIPAL_INVESTIGATOR
Yeditepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tekirdağ Namık Kemal Univercity
Tekirdağ, Süleymanpaşa, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YeditepeU 312
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.